CPhI Japan

CPhI Japan, held annually since 2002, is a flagship event in the global CPhI series. It provides exhibitors with a premier platform to showcase their latest pharmaceutical ingredients, technologies, and solutions. The exhibition covers a comprehensive range of products including APIs, formulations, biologics, synthetic drugs, manufacturing equipment, packaging materials, and pharmaceutical processing technologies. Additionally, it features dedicated zones and discussions on drug R&D, production, quality control, and regulatory compliance.

The event attracts hundreds of exhibitors from over 30 countries and regions, drawing approximately 20,000 pharmaceutical professionals from more than 20 countries for business matchmaking and the unveiling of cutting-edge technologies. Since its strategic rebranding in 2023, CPhI Japan has been positioned as a one-stop exhibition for pharmaceutical development from drug discovery to manufacturing, dedicated to supporting new drug development and ensuring stable supply chains.

CPhI Japan typically features a comprehensive conference program, including seminars, keynote lectures, and panel discussions. These sessions delve into the latest industry developments, market trends, innovative research, and regulatory updates, offering attendees in-depth insights into the pharmaceutical sector.

Facing anticipated market growth fluctuations, Japan's pharmaceutical industry is not only focusing on developing new anticancer drugs as a market leader but also actively advancing mid-molecule biologics such as nucleic acids and peptides, gene and cell therapies, and digital transformation. The industry is continuously exploring innovative business models and new paradigms for sustainable growth.

In recent years, as pharmaceutical development cycles lengthen and R&D costs continue to rise, companies are increasingly outsourcing development and manufacturing processes to CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development and Manufacturing Organizations). This trend is particularly pronounced in the biopharma sector, where collaboration with external partners has become essential for startups and established firms alike.

To address these evolving industry needs, CPhI Japan leverages its exhibition and conference platforms to showcase the latest domestic and international technological trends and share practical expertise. (Copyright © Juzhan. All rights reserved. Unauthorized reproduction is prohibited.)

CPhI Japan tickets are e-tickets. Domestic and international visitors must complete online pre-registration with real-name passport verification. After purchase, the organizer verifies visitor identity. Visitors who do not meet entry requirements may need to submit additional documents. Once approved, you will receive email confirmation or a QR code. On site, present your original passport and confirmation letter to collect a paper badge, or scan the QR code to enter.

Partial exhibitor directory and exhibitor list for CPhI Japan: Anhui Royal Chemical Co.,Ltd, Asahi Kasei Corporation, FIS, HEBEI DAPENG PHARM & CHEM CO. LTD, Japan Active Pharmaceutical Ingredient Association, and others. The 2027 edition is expected to feature 500+ exhibiting companies. To obtain the full exhibitor directory (including booth numbers and contact details), please visit the official exhibition website or contact Jufair.